
|Articles|July 1, 2001
Should MVAC be standard of care for bladder Ca?
San Francisco-Results from a 14-year Southwest Oncology Group trial show for the first time that neoadjuvant chemotherapy plus cystectomy offers improved survival over cystectomy alone in the treatment of patients with locally advanced bladder cancer. This finding challenges the results of seven previous clinical studies.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
3
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
4
Study suggests potential diuretic effect with nadofaragene firadenovec
5











